#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3252	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2527	381.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1800	1800	T	481	T	411	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3252	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2527	381.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1534	1534	C	518	C,A	423,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3252	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2527	381.7	0	HET	.	.	.	A69G	.	69	69	A	419	419	A	472	A,G	313,72	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3252	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2527	381.7	0	HET	.	.	.	G642A	.	642	642	G	992	992	G	524	G,A	318,104	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5468	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4026	406.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1920	1920	A	442	A,G	357,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5468	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4026	406.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2554	2554	C	483	C,A,T	395,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5468	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4026	406.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2628	2628	A	503	A,C	414,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5468	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4026	406.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3180	3180	C	498	C,G,A	397,1,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	440	folP	852	852	99.88	folP.l15.c4.ctg.1	1774	73.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	934	936	AAA	87;88;88	A;A;A	72;73;70	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	440	folP	852	852	99.88	folP.l15.c4.ctg.1	1774	73.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1165	1167	AGC	107;107;107	A,C;G;C	87,1;89;87	folP.WHO_M_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	962	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3864	74.5	1	SNP	p	S91F	0	.	.	271	273	TCC	858	860	TCC	89;89;89	T;C;C	69;74;72	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	962	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3864	74.5	1	SNP	p	D95G	0	.	.	283	285	GAC	870	872	GAC	85;84;85	G;A;C	71;68;70	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	962	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3864	74.5	1	SNP	p	D95N	0	.	.	283	285	GAC	870	872	GAC	85;84;85	G;A;C	71;68;70	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	414	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1663	74.3	1	SNP	p	G45D	0	.	.	133	135	GGC	601	603	GGC	113;112;112	G;G;C	92;92;90	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	196	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1229	47.4	0	.	n	.	0	A197.	DEL	197	197	A	729	729	A	86	A	68	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	964	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3306	87.3	1	SNP	p	D86N	0	.	.	256	258	GAC	767	769	GAC	114;114;114	G;A,C;C,A	93;90,1;90,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	964	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3306	87.3	1	SNP	p	S87I	0	.	.	259	261	AGT	770	772	AGT	114;115;115	A;G;T,G	91;94;89,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	964	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3306	87.3	1	SNP	p	S87R	0	.	.	259	261	AGT	770	772	AGT	114;115;115	A;G;T,G	91;94;89,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	964	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3306	87.3	1	SNP	p	S87W	0	.	.	259	261	AGT	770	772	AGT	114;115;115	A;G;T,G	91;94;89,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	964	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3306	87.3	1	SNP	p	S88P	0	.	.	262	264	TCC	773	775	TCC	115;115;115	T;C;C	90;93;94	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	928	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3006	92.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1768	1770	GGC	110;109;109	G;G;C	84;83;86	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2783	90.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1478	1480	GCA	129;127;129	G;C;A	100;97;101	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2783	90.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1481	1483	ATC	130;130;129	A;T,G;C	106;102,1;104	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2783	90.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1493	1495	GTG	129;129;128	G;T,G;G	103;100,1;100	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2783	90.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1493	1495	GTG	129;129;128	G;T,G;G	103;100,1;100	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2783	90.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1997	1999	ACC	100;100;99	A;C;C	84;84;89	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2783	90.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2051	2053	GCG	111;111;111	G;C;G	85;79;80	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2783	90.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2051	2053	GCG	111;111;111	G;C;G	85;79;80	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2783	90.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2174	2176	GGC	108;108;108	G;G;C	86;81;86	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2783	90.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2183	2185	GGC	107;107;107	G;G;C,T	84;87;83,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2783	90.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2201	2203	CTG	113;113;112	C;T;G,T	91;89;88,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1012	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3258	92.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1666	1668	CCG	69;69;70	C;C,G;G	56;56,1;57	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	476	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2176	65.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	777	777	C	64	C	54	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	682	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1849	108.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	575	577	GAA	139;140;139	G;A;A	111;113;112	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	682	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1849	108.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	863	865	GAT	132;131;131	G;A;T,G,A	103;104;105,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	682	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1849	108.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	986	988	TCA	115;115;117	T;C;A	90;93;91	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	682	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1849	108.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1115	1117	GTC	123;124;126	G;T;C	99;102;100	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	682	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1849	108.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1127	1129	TCT	128;127;127	T;C;T,G	103;103;100,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	682	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1849	108.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1445	1447	GCA	173;173;171	G;C;A	130;129;133	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	682	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1849	108.3	1	SNP	p	G120K	1	.	.	358	360	AAG	821	823	AAG	138;137;137	A,C;A;G	107,1;106;109	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	682	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1849	108.3	1	SNP	p	A121D	1	.	.	361	363	GAC	824	826	GAC	136;135;135	G;A;C	109;104;105	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	682	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1849	108.3	1	SNP	p	D121N	0	.	.	361	363	GAC	824	826	GAC	136;135;135	G;A;C	109;104;105	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2434	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5179	140.7	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2191	2193	AAT	140;142;143	A;A,C;T	117;120,1;121	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	362	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1324	81.6	1	SNP	p	V57M	1	.	.	169	171	ATG	625	627	ATG	153;151;153	A;T;G	126;120;125	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
